Champions Oncology (CSBR) Assets Average (2011 - 2026)

Champions Oncology has reported Assets Average for 16 years, with the latest figure at $27.7 million in Q2 2026.

• On a quarterly basis, Assets Average fell 11.97% year-over-year to $27.7 million in Q2 2026; TTM through Apr 2026 was $27.7 million, a 11.97% decrease from a year earlier, with the FY2026 full-year figure at $29.7 million, up 1.47% from the prior year.
• Assets Average was $27.7 million for Q2 2026 at Champions Oncology, down from $29.3 million in the prior quarter.
• The five-year high for Assets Average was $36.3 million in Q1 2023, with the low at $25.1 million in Q4 2024.
• Average Assets Average over 5 years is $30.7 million, with a median of $30.9 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Assets Average surged 30.48% in 2022, then fell 24.9% in 2024.
• Over 5 years, Assets Average stood at $35.4 million in 2022, then slipped by 17.74% to $29.1 million in 2023, then decreased by 13.79% to $25.1 million in 2024, then grew by 21.0% to $30.4 million in 2025, then fell by 8.68% to $27.7 million in 2026.
• The last three Assets Average figures came in at $27.7 million (Q2 2026), $29.3 million (Q1 2026), and $30.4 million (Q4 2025), per Business Quant data.